Document
IPR2024-00009, No. 1057 Exhibit - WO 2011073328 (P.T.A.B. Oct. 20, 2023)
Cite Document
IPR2024-00009, No. 1057 Exhibit - WO 2011073328 (P.T.A.B. Oct. 20, 2023)
+ More Snippets
Document
IPR2024-00009, No. 1093 Exhibit - Declaration of Dr John P Fruehauf (P.T.A.B. Oct. 20, 2023)
Cite Document
IPR2024-00009, No. 1093 Exhibit - Declaration of Dr John P Fruehauf (P.T.A.B. Oct. 20, 2023)
+ More Snippets
Document
IPR2024-00009, No. 1003 Exhibit - Declaration of John Bantle, MD (P.T.A.B. Oct. 20, 2023)
Cite Document
IPR2024-00009, No. 1003 Exhibit - Declaration of John Bantle, MD (P.T.A.B. Oct. 20, 2023)
+ More Snippets
Document
IPR2024-00009, No. 1058 Exhibit - Blonde, Comparison of Liraglutidesuppl 2 DIABETES, OBES, METAB 2012 (P.T.A.B. Oct. 20, 2023)
Cite Document
IPR2024-00009, No. 1058 Exhibit - Blonde, Comparison of Liraglutidesuppl 2 DIABETES, OBES, METAB 2012 (P.T.A.B. Oct. 20, 2023)
+ More Snippets
Document
IPR2024-00009, No. 1076 Exhibit - ClinicalTrialsgov Background, CLINICALTRIALSGOV (P.T.A.B. Oct. 20, 2023)
Cite Document
IPR2024-00009, No. 1076 Exhibit - ClinicalTrialsgov Background, CLINICALTRIALSGOV (P.T.A.B. Oct. 20, 2023)
+ More Snippets
Document
IPR2024-00009, No. 1067 Exhibit - US Patent No 8,536,122 (P.T.A.B. Oct. 20, 2023)
Cite Document
IPR2024-00009, No. 1067 Exhibit - US Patent No 8,536,122 (P.T.A.B. Oct. 20, 2023)
+ More Snippets
Document
IPR2024-00009, No. 1086 Exhibit - “Last Update Posted” definition from ClinicalTrialsgov (P.T.A.B. Oct. 20, 2023)
Cite Document
IPR2024-00009, No. 1086 Exhibit - “Last Update Posted” definition from ClinicalTrialsgov (P.T.A.B. Oct. 20, 2023)
+ More Snippets
Document
IPR2024-00009, No. 1068 Exhibit - US Patent No 8,129,343 (P.T.A.B. Oct. 20, 2023)
Cite Document
IPR2024-00009, No. 1068 Exhibit - US Patent No 8,129,343 (P.T.A.B. Oct. 20, 2023)
+ More Snippets
Document
IPR2024-00009, No. 1035 Exhibit - Lund, Emerging GLP 1 Receptor, 6 EXPERT OP ON EMERGING DRUGS 607 2011 (P.T.A.B. Oct. 20, 2023)
Cite Document
IPR2024-00009, No. 1035 Exhibit - Lund, Emerging GLP 1 Receptor, 6 EXPERT OP ON EMERGING DRUGS 607 2011 (P.T.A.B. Oct. 20, 2023)
+ More Snippets
Document
IPR2024-00009, No. 1063 Exhibit - Kirillova, Results and Outcome,76 PLOS ONE 1 2012 (P.T.A.B. Oct. 20, 2023)
Cite Document
IPR2024-00009, No. 1063 Exhibit - Kirillova, Results and Outcome,76 PLOS ONE 1 2012 (P.T.A.B. Oct. 20, 2023)
+ More Snippets
Document
IPR2024-00009, No. 1001 Exhibit - US Patent No 10,335,462 (P.T.A.B. Oct. 20, 2023)
Cite Document
IPR2024-00009, No. 1001 Exhibit - US Patent No 10,335,462 (P.T.A.B. Oct. 20, 2023)
+ More Snippets
Document
IPR2024-00009, No. 1053 Exhibit - Møller, Mechanism Based, 38 J PHARMACOKINETICS 713 2011 (P.T.A.B. Oct. 20, 2023)
Cite Document
IPR2024-00009, No. 1053 Exhibit - Møller, Mechanism Based, 38 J PHARMACOKINETICS 713 2011 (P.T.A.B. Oct. 20, 2023)
+ More Snippets
Document
IPR2024-00009, No. 1022 Exhibit - Drab, Incretin Based Therapies for Type 2 Diabetes PHARMA 609 2010 (P.T.A.B. Oct. 20, 2023)
Cite Document
IPR2024-00009, No. 1022 Exhibit - Drab, Incretin Based Therapies for Type 2 Diabetes PHARMA 609 2010 (P.T.A.B. Oct. 20, 2023)
+ More Snippets
Document
IPR2024-00009, No. 1002 Exhibit - Prosecution history excerpts for US Patent No 10,335,462 (P.T.A.B. Oct. 20, 2023)
Cite Document
IPR2024-00009, No. 1002 Exhibit - Prosecution history excerpts for US Patent No 10,335,462 (P.T.A.B. Oct. 20, 2023)
+ More Snippets
Document
IPR2024-00009, No. 1018 Exhibit - Banting, The Internal Secretion of the Pancreas, 7 J LAB CLINICAL MED 25 (P.T.A.B. Oct. 20, 2023)
Cite Document
IPR2024-00009, No. 1018 Exhibit - Banting, The Internal Secretion of the Pancreas, 7 J LAB CLINICAL MED 25 (P.T.A.B. Oct. 20, 2023)
+ More Snippets